1. Stojanka Arsić, Olivera Žikić, Aleksandra Kostić, Biljana Kocić, Gordana Kostić, Danijela Radojković, Dragan Đorđević, Dragana Radović Janošević, Branka Mitić, Zorica Dimitrijević, Ranko Kutlešić, Predrag Vukomanović, Gordana Stanković Babić, Mila Bojanović, Ivan Petković, Olivera Radulović, Roberta Marković, Emina Kostić, Emilija Živković Marinkov. Uvod u kliničku praksu-komunikacija u medicini. Medicinski fakultet Niš 2022. Autor poglavlja: Komunikacija sa onkološkim pacijentom. pp 17-30. ISBN 978-86-6265-112-9
1. Dane Krtinić, Gorana Nedin Ranković, Ivan Petković, Ana Cvetanović, Irena Conić, Mirjana Todorović Mitić, Milica Radić, Boris Milisavljević, Aleksandra Lučić Prokin, Vladimir Đorđević, Hristina Jovanović, Hristina Trajković, Marija Anđelković, Dragana Milijašević, Ranko Zdravković, Iva Binić. The role of tapentadol in the cancer pain pharmacotherapy in patients with metastatic malignant disease. Eur Rev Med Pharmacol Sci 2023; 27 (24): 12112-12120. doi: 10.26355/eurrev_202312_34809PMID: awaiting IF2022: 3.3 (M22) 5-IF2022: 3.1
2. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević. Andrija Jović. Prognostic value of lactate dehydrogenase in melanoma patients treated with pembrolizumab. Acta Dermatovener Cr 2023; 31 (2): 86-91. PMID:38006368 IF2022: 0.6 (M23) 5-IF2022: 1.1
3. Vanja Đurić, Bojana Stamenković, Ivan Petković, Luka Đurić. Prevalence of various forms of peripheral neuropathy in patients with systemic connective tissue diseases: a clinical and electrophysiological study. Vojnosanit Pregl 2023; 80 (7): 561-9. doi: 10.2298/VSP211005090D PMID: suppresed IF2022: 0.2 (M23) 5-IF2022: 0.2
4. Miljana Džunić, Ana Cvetanović, Ivan Petković, Ivana Todorović Stojanović. Pathologic complete response in metastatic right-sided colon cancer treated with panitumumab and FOLFOX4 chemotherapy regimen. Srpski Arhiv 2022; 150 (11-12):716-20. doi:10.2298/SARH220419082D IF2022: 0.2 (M23) 5-IF2021: 0.2
5. Miljan Krstic, Slavica Stojnev, Ivan Petkovic, Irena Conic, Janko Zujovic, Velimir Milosevic. Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center. J BUON 2021; 26 (6): 2536-43. PMID: suppresed IF2020: 2.533 (M23) 5-IF2020: 1.987
6. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. EBV negative angioimmunoblastic T–cell lymphoma with sequential development of diffuse large B–cell lymphoma in course of progression. Indian J Hematol Blood Transfus 2021; 37 (4): 694-6. doi:10.1007/s12288-021-01425-w PMID: 34744354 IF2021: 0.915 (M23) 5-IF2021 : 1.003
7. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Extranodal NK/T–cell lymphoma, nasal type overlapping aggressive NK–cell leukemia in course of progression. UHOD-Uluslar Hematol 2020; 30 (4): 248-51. doi:10.4999/uhod.204767 IF2020: 0.200 (M23) 5-IF 2020: 0.230
8. Miljana Dzunic, Marija Andjelkovic-Apostolovic, Svetislav Vrbic, Ivica Pejcic, Ivan Petkovic, Ana Cvetanovic, Sasa Dinic. Survival of patients with liver metastases from colorectal cancer treated with bevacizumab and FOLFOX4. J BUON 2020; 25 (1): 212-9. PMID: 32277634 IF (2020): 2.533 (M23) 5-IF2020: 1.987
9. Miljana Dzunic, Ivan Petkovic, Ana Cvetanovic, Svetislav Vrbic, Ivica Pejcic. Current and future targets and therapies in metastatic colorectal cancer - Status Change. J BUON 2019; 24 (5): 1785-92. PMID: 31786838 IF 2019: 1.695 (M23) 5-IF 2019: 1.453
10. Slavica Stojnev, Miljan Krstić, Jovana Čukuranović Kokoris, Irena Conić, Ivan Petković, Sonja Ilić, Jelena Milošević Stevanović, Ljubinka Janković Veličković. Prognostic impact of canonical TGF-β signaling in urothelial bladder cancer. Medicina (Kaunas) 2019;55 (6): 302. doi:10.3390/medicina55060302 PMID: 31238579 IF (2019): 1.205 (M23) 5-IF 2019: 1.572
11. Darko Antic, Jelena Jelicic, Goran Trajkovic, Milena Todorovic Balint, Jelena Bila, Olivera Markovic, Ivan Petkovic, Vesna Nikolic, Bosko Andjelic, Vladislava Djurasinovic, Aleksandra Sretenovic, Mihailo Smiljanic, Vojin Vukovic, Biljana Mihaljevic. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B-cell lymphoma? The prognostic significance of comorbidities. Ann Hematol 2018; 97 (2): 267-76. doi: 10.1007/s00277-017-3170-z PMID: 29130134 IF 2018: 2.850 (M22) 5-IF 2018: 2.811
12. Olivera Simonović, Milena Todorović, Biljana Mihaljević, Tatjana Stoimenov-Jevtović, Ivan Petković, Lana Mačukanović-Golubović, Goran Marjanović. Serum biomarkers and clinical characteristics of patients with classical Hodgkin lymphoma. Vojnosanit Pregl 2018; 75 (9): 911-917. doi: 10.2298/VSP160705018S PMID: awaiting IF 2018: 0.272 (M23) 5-IF 2018: 0.418
13. Slavica Stojnev, Miljan Krstić, Ivan Ilić, Ivan Petković, Simonida Stojanović, Predrag Cvetković, Pavle Randjelović, Ljubinka Veličković. Acute myocardial infarction with Trousseau’s syndrome: case report and review of the literature. W Indian Med J 2017; u štampi doi:10.7727/wimj.2016.140 PMID: awaiting IF 2016: 0.224 (M23) 5-IF 2016 0.3
14. Ivan Petković, Ivica Pejčić, Danica Tiodorović, Miljan Krstić, Slavica Stojnev, Svetislav Vrbić. Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type. Postepy Dermatol Alergol 2017; 34 (6): 625-8. doi:10.5114/pdia.2017.66625 PMID: 29422831 IF 2017: 1.471 (M23) 5-IF 2017: 1.407
15. Biljana Mihaljevic, Jelena Jelicic, Boško Andjelic, Darko Antic, Olivera Markovic, Ivan Petkovic, Maja Perunicic Jovanovic, Goran Trajkovic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Milena Todorovic Balint. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. Int J Hematol 2016; 104 (6): 692–9. doi: 10.1007/s12185–016–2099–7 PMID: 27714586 IF 2016: 1.610 (M23) 5-IF 2016: 1.621
16. Ivan Petković, Slavica Stojnev, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence? Vojnosanit Pregl 2016; 73 (11): 1072-75. doi: 10.2298/VSP150425125P PMID: 29341562 IF 2016: 0.367 (M23) 5-IF 2016: 0.382
17. Ivan Petković. Current trends in the treatment of primary mediastinal large B-cell lymphoma-an overview. Contemp Oncol (Pozn) 2015; 19 (6): 428-35. doi:10.5114/wo.2015.56388 PMID: 26843837 5-IF: 0.150 (M23)
18. Ivan Petkovic. Follicular lymphoma-reply. Turk J Hematol 2015; 32 (1): 95. doi: 10.4274/tjh.2014.0380 PMID: 25805689 IF 2015: 0.827 (M26) 5-IF2015: 0.579
19. Ivan Petković, Ivica Pejčić, Svetislav Vrbić. Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma? Contemp Oncol (Pozn) 2014; 18 (6): 377-83. doi: 10.5114/wo.2014.45111 PMID: 25784834 5-IF: 0.150 (M23)
20. Ivan Petković, Miljan Krstić, Ivica Pejcić, Svetislav Vrbić, Slavica Stojnev, Ana Cvetanović, Mirjana Balić, Mirjana Todorović. Renal infiltration of Follicular Lymphoma. Turk J Hematol 2014; 31 (3): 315-6. doi: 10.4274/Tjh.2014.0013 PMID: 25330530 IF 2014: 0.360 (M23) 5-IF 2014: 0.359
21. Ivica Pejcic, Ivan Petkovic, Svetislav Vrbic, Sladjana Filipovic, Mirjana Balic, Ana Cvetanovic. Mantle cell lymphoma-current literature overview. J BUON 2014; 19 (2): 342-9. PMID: 24965390 IF 2014: 0.761 (M23) 5-IF 2014: 0.686
22. Ana Cvetanovic, Svetislav Vrbic, Sladjana Filipovic, Ivica Pejcic, Dusan Milenkovic, Nikola Zivkovic, Milos Kostic, Ivan Petkovic. Clinical benefit of Cetuximab and prognostic values of Cetuximab-related skin toxicity in metastatic colorectal cancer: a single institution analysis. J BUON 2014; 19 (1): 83-90. PMID: 24659647 IF 2014: 0.761 (M23) 5-IF 2014: 0.686
23. Ivica Pejcic, Svetislav Vrbic, Sladjana Filipovic, Mirjana Scekic, Ivan Petkovic, Ljiljana Pejcic. Concurrent chemoimmunotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status? J BUON 2010; 15 (3): 470-4. PMID: 20954411 IF 2010: 0.482 (M23) 5-IF 2010: 0.6
24. Ivica Pejčić, Svetislav Vrbić, Slađana Filipović, Mirjana Šćekić, Ivan Petković, Ljiljana Pejčić, Nebojša Đenić. Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site. Vojnosanit Pregl 2010; 67 (9): 723-31. doi:10.2298/VSP1009723P PMID: 20954411 IF 2010: 0.199 (M23) 5-IF 2010: 0.2
1. Aleksandar Popović, Ivan Petković, Andrija Rančić, Aleksandra Dimitrijević, Vesna Brzački, Andrija Jović, Stefan Stankov, Sonja Stojanović. Nivolumab in patient with mucosal melanoma and systemic lupus-case report and a literature review. Acta Fac Med Naiss 2023; 40 (4): 505-11. doi: 10.5937/afmnai40-40566 (M51) IF2022:0.2
2. Miljana Džunić, Ana Cvetanović, Ivan Petković. Perimandibular metastasis of rectal cancer: a case report. Acta Fac Med Naiss 2023; 40 (3): 352-7. doi: 10.5937/afmnai40-38706 (M51) IF2022:0.2
3. Ivan Petković. Chemotherapy induced assymmetrical melanonychia. Acta Fac Med Naiss 2022; 39 (3): 380-4. doi: 10.5937/afmnai39-36282 (M51) IF2022:0.2
4. Miljan Krstić, Slavica Stojnev, Ivan Petković. Mantle cell lymphoma- a killer with a face of a child. Acta Medica Medianae 2022; 61 (1): 23-9. doi: 10.5633/amm.2022.0103 (M52)
5. Miljana Džunić, Ivan Petković, Ana Cvetanović, Ivica Pejčić, Svetislav Vrbić, Saša Dinić. Prognostic parameters in patients with resected liver metastases from colorectal cancer after biological and chemotherapy. Acta Fac Med Naiss 2020; 37 (4): 349-58. doi: 10.5937/afmnai2004349D (M51)
6. Ivan Petković, Aleksandar Popović, Miljana Džunić, Ivica Pejčić. Nodal and extranodal peripheral T/NK-cell neoplasms: current aspects. Acta Fac Med Naiss 2020; 37 (2): 99-120. doi: 10.5937/afmnai37-24708 (M51)
7. Miljana Džunić, Bojana Pejčić, Marija Anđelković-Apostolović, Svetislav Vrbić, Ivica Pejčić, Ivan Petković. Predictors of therapy response and early reccurence in patients with potentially resectabile colorectal liver metastases treated with bevacizumab and FOLFOX4 as a conversion therapy. Acta Medica Medianae 2019; 58 (3): 72-9. doi: 10.5633/amm.2019.0310 (M51)
8. Mladen Đorđević, Ivan Petković. Dichlor-acetate induced polyneuropathy in high grade follicular lymphoma patient. Acta Medica Medianae 2019; 58 (1): 102-5. doi: 10.5633/amm.2019.0114 (M51)
9. Ivica Pejčić, Ivan Petković, Ana Cvetanović, Irena Conić. Single center experience study with Pembrolizumab in patients with BRAF mutant negative metastatic melanoma. Acta Fac Med Naiss 2018; 35 (4): 267-72. doi: 10.2478/afmnai-2018-0028 (M51)
10. Slavica Stojnev, Ana Ristić, Miljan Krstić, Ana Ristić-Petrović, Irena Conić, Ivan Petković, Jelena Milenković, Ljubinka Janković-Veličković. Expression of epigenetic silencer EZH2 in early invasive pT1 urothelial bladder cancer. Acta Medica Medianae 2018; 57 (3): 48-54. doi: 10.5633/amm.2018. 0306 (M51)
11. Novica Dimić, Dragan Krasić, Bojana Stamenković, Marina Vlajković, Ivan Petković, Dragan Dimić, Miljan Krstić, Nikola Živković, Dušanka Marković. MALT lymphoma in primary Sjogren’s syndrome patient-a case report. Balneoclimatologia 2018; 42 (1): 229-39. (M53)
12. Jovan Nikolić, Aleksandra Milićević, Jadranka Paravina, Ivan Petković, Milica Mihailović, Miloš Stanković, Žaklina Mijović, Dragan Mihailović. Histopathologic and clinical features of rapidly progressive ALK-negative cutaneous anaplastic large T-cell lymphoma. Acta Medica Medianae 2017; 56 (3): 55-61. doi: 10.5633/amm.2017.0309 (M51)
13. Miodrag Vrbić, Ivan Petković, Svetislav Vrbić, Maja Jovanović, Aleksandar Ranković, Lidija Popović-Dragonjić, Marina Djordjević-Spasić. Two-Year Complete Remission of Diffuse Large B-cell Lymphoma in an Immunological Nonresponder HIV -infected Patient: Case Report. Case Rep Oncol 2017; 10 (1): 356-360. doi: 10.1159/0004718472 PMID: 28559819 (M51)
14. Ivan Petković, Ivica Pejčić, Svetislav Vrbić. Proteazomni inhibitori-racionala kliničke primene u tretmanu multiplog mijeloma. Racionalna Terapija 2016; 8 (2): 25-33. doi: 10.5937/racter8-10447 (M52)
15. Ivan Petković, Miljan Krstić, Slavica Stojnev, Ivica Pejčić, Svetislav Vrbić. Extensive bone marrow involvement in Hodgkin lymphoma patient. Acta Fac Med Naiss 2014; 31 (4): 261-5. doi: 10.2478/afmnai-2014-0032 (M52)
16. Ivica Pejčić, Svetislav Vrbić, Mirjana Todorović, Ivan Petković, Mirjana Balić, Ana Stanković. Cancer of unknown primary site syndrome-CUP syndrome-diagnostic and therapeutic dillemas. Acta Fac Med Naiss 2014; 31 (2): 87-94. doi: 10.2478/afmnai-2014-0010 (M52)
17. Ivan Petković, Ivica Pejčić, Svetislav Vrbić. New frontiers of target therapy in oncology: acute promyelocytic leukemia. Acta Fac Med Naiss 2014; 31 (1): 17-28. doi: 10.2478/afmnai-2014-0002 (M52)
18. Ivan Petković, Dragan Mihailović, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Burkitt lymphoma in elderly patients – a case report. Acta Fac Med Naiss 2013; 30 (2): 103-9. doi: 10.2478/v10283-012-0044-0 (M52)
19. Ivan Petković, Dragan Mihailović, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Primary mantle cell lymphoma of gastrointestinal tract - a case report. Acta Medica Medianae 2012; 51 (3): 41-6. doi: 10.5633/amm.2012.0307 (M52)
1. Slavica Stojnev, Miljan Krstic, Ana Ristic Petrovic, Irena Conic, Ivan Petkovic, J Todorovic, M Mladenovic, Ljubinka Jankovic Velickovic. Prognostic significance of death receptors expression in primary and recurrent T1 bladder cancer [Meeting Abstract]. Virchows Archiv 2023; 483 (1) (Suppl 1): S143. PS-26-024 35th European Congress of Pathology 2023 Dublin, Ireland (M34)
2. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Lidija Kandolf, Branko Dujović, Ivana Jocić, Marina Petronijević, Andrija Jović, MIrjana Todorović Mitić, MIrjana Balić, Philipp Schnecks. Response to anti-PD1 treatment in acral melanoma [Meeting Abstract]. Abstract book Id27. 19th EADO Congress 20-22. April 2023 Rome, Italia (M34)
3. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Lidija Kandolf, Branko Dujović, Ivana Jocić, Marina Petronijević, Andrija Jović, MIrjana Todorović Mitić, MIrjana Balić, Philipp Schnecks. Response to anti-PD1 treatment in cutaneous head and neck melanoma [Meeting Abstract]. Abstract book Id27. 19th EADO Congress 20-22. April 2023 Rome, Italia (M34)
4. Aleksandar Popović, Ivan Petković, Dimitrijević Aleksandra, Balić Mirjana, Jović Andrija, Dujović Branko, Lidija Kandolf Sekulović, Ivica Pejčić. Prognostic Value of Lactate Dehydrogenase in Melanoma Patients Treated With Pembrolizumab [Meeting Abstract]. Abstract book p Id26. 18th EADO Congress 21-23. April 2022. Sevilla, Espana (M34)
5. Aleksandar Popović, Ivan Petković, Balić Mirjana, Dimitrijević Aleksandra, Tiodorović Danica, Spasić D, Stevanović Goran, Jović Andrija, Ivica Pejčić. Single Center Experience with Pembrolizumab in Therapy Naive Advanced Melanoma Patients [Meeting Abstract]. Abstract book p Id27. 18th EADO Congress 21-23. April 2022. Sevilla, Espana (M34)
6. Slavica Stojnev, Miljan Krstic, Ana Ristic, Ivan Petkovic, Irena Conic, Ana Ristic Petrovic, J Todorovic, M Mladenovic. Association of STAT3 expression and enhanced angiogenesis in primary extranodal diffuse large B cell lymphoma [Meeting Abstract]. Virchows Archiv 2021; 479 (1) (Suppl 1): S116. PS-10-008 33rd European Congress of Pathology 2021 Gothenburg, Sweden (M34)
7. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Stefan Stankov, Ivica Pejčić, Svetislav Vrbić. Single center experience study with pembrolizumab in patients with unresectable and metastatic melanoma [Meeting Abstract]. Libri Oncologici 2021; 49 (suppl 2): 67. 3rd Rekonio Conference-Regional Balcan Oncology Meeting 2021 (M34)
8. Aleksandar Popović, Branko Dujović, Ivan Petković, Danica Tiodorović, Lidija Kandolf Sekulović, Aleksandra Dimitrijević, Andrija Jović, Ivica Pejčić. Significance of body mass index on the efficacy and safety profile of pembrolizumab in melanoma patients [Meeting Abstract]. Abstract book p 168, 204. 10th World Congress of Melanoma in conjuction with 17th EADO, 15-17. april 2021. (M34)
9. Miljan Krstic, Maja Perunicic Jovanovic, Slavica Stojnev, Petar Jovanovic Ivan Petkovic, Darko Antic. Clinicopathologic analysis of splenic lymphoma: three year experinece [Meeting Abstract]. Abstract book pp 64, 134-5. EAHP 19th Meeting of the European Association for Haematopathology, Edinburgh, Scotland, United Kingdom 2018 (M34)
10. Jelena Jelicic, Darko Antic, Milena Todorovic Balint, Bosko Andjelic, Olivera Markovic, Ivan Petkovic, Vesna Nikolic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Snezana Sretenovic, Biljana Mihaljevic. High comorbidity index along with high NCCN-IPI strongly influence survival of diffuse large B cell lymphoma patients: Serbian Lymphoma Group experience [Meeting Abstract]. Haematologica 2017; 102 (Suppl 2): 399. (M34)
11. Jelena Jelicic, Darko Antic, Milena Todorovic Balint, Bosko Andjelic, Olivera Markovic, Ivan Petkovic, Vesna Nikolic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Snezana Sretenovic, Biljana Mihaljevic. Low albumin level correlates with poorer survival of patients with diffuse large B cell lymphoma: Serbian Lymphoma Group experience [Meeting Abstract]. Haematologica 2017; 102 (Suppl 2): 688. (M34)
12. Miljan Krstic, Slavica Stojnev, Ivan Petkovic. STAT3 expression in diffuse large B–cell lymphoma of nodal and extranodal localization [Meeting Abstract]. Abstract book pp 75, 145-6. EAHP 18th Meeting of the European Association for Haematopathology, Basel, Switzerland 2016 (M34)
13. Jelena Jelicic, Milena Todorovic, Bosko Andjelic, Darko Antic, Olivera Markovic, Ivan Petkovic, Aleksandra Sretenovic, Jelena Bila, Vojin Vukovic, Vladislava Djurasinovic, Mihailo Smiljanic, Ivica Pejicic, Biljana Mihaljevic. The absolute lymphocyte count as independent pararmeter may predict prognosis of follicular lymphoma patients [Meeting Abstract]. Haematologica 2016; 101 (Suppl 1): 753. (M34)
14. Jelena Jelicic, Milena Todorovic Balint, Darko Antic, Bosko Andjelic, Olivera Markovic, Ivan Petkovic, Aleksandra Sretenovic, Jelena Bila, Vojin Vukovic, Vladislava Djurasinovic, Mihailo Smiljanic, Ivica Pejicic, Biljana Mihaljevic. Analysis of clinical parameters, absolute lymphocyte count in patients with diffuse large B cell lymphoma [Meeting Abstract]. Haematologica 2016; 101 (Suppl 1): 706. (M34)
15. Jelena Jelicic, Milena Todorovic, Darko Antic, Jelena Bila, Bosko Andjelic, Dejana Stanisavljevic, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihajlo Smiljanic, Ivan Petkovic, Ivica Vrbic, Biljana Mihaljevic. The role of prognostic and comorbidity indexes in patients with diffuse large B cell lymphoma treated with immunochemotherapy [Meeting Abstract]. Haematologica 2015; 100 (Suppl 1): 660-1. (M34)
16. Vesna Nikolić, Darko Antić, Boško Andjelić, Milena Todorović, Tomislav Vukićević, Ivica Pejčić, Ivan Petković, Stevan Popović, Lazar Popović, Nebojša Andjelković, Snežana Sretenović, Olivera Marković, Jelena Knežević, Biljana Mihaljević. Prognostički značaj Ki-67 indeksa u bolesnika sa difuznim krupnoćelijskim B-limfomom koji su lečeni Rituximabom plus CHOP-iskustva Srpske limfomske grupe [Meeting Abstract]. 2. Kongres hematologa Srbije/6th Balkan Day Haematology, Belgrade 2011. Abstract book pp 08, 23-5. (M34)
17. Mihaljević Biljana, Antić Darko, Anđelić Boško, Todorović Milena, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Smiljanić Mihailo, Marković Olivera. Prognostic significance of the Ki-67 index in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP-experience of Serbian Lymphoma Study Group [Meeting Abstract]. Haematologica 2011; 96 (Suppl 2): 575-6. (M34)
18. Mihaljević Biljana, Antić Darko, Anđelić Boško, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Stevan, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Leković Danijela, Smiljanić Mihailo, Marković Olivera, Knežević V, Kecman Vladimir. Characteristics of 917 Non-Hodgkin Lymphoma Patients in Serbia According to the WHO Classification of Lymphoid Neoplasms-Lira National Register-Based Study [Meeting Abstract]. Ann Oncol 2011; 22 (4): 204. (M34)
19. Mihaljević Biljana, Anđelić Boško, Antić Darko, Todorović Milena, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Stevan, Savić Ivanka, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Knežević Jelena, Kecman Vladimir. Diffuse Large B-cell Lymphoma: Germinal Center Vs Non Germinal Center - Treatment Response on Immunochemotherapy. Serbian Lymphoma Study Group [Meeting Abstract]. Ann Oncol 2011; 22 (4): 224-5. (M34)
1. Dane Krtinić, Dragana Stokanović, Gorana Nedin Ranković, Ivan Petković, Ana Cvetanović, Irena Conić, Aleksandar Stojanov, Hristina Jovanović, Hristina Trajković, Milan Čevrljaković. Značaj transdermalnih formulacija opioidnih analgetika u farmakoterapiji bola. Abstract Book pp 26. Nedelja bolničke kliničke farmakologije 2023.online (M64)
2. Ivan Petković, Aleksandar Popović, Mirjana Balić. Polatuzumab-Vedotin+Bendamustin+Rituksimab kao “most” ka autolognoj transplantaciji – prikaz slučaja. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
3. Ivan Petković, Aleksandar Popović, Marija Jevtić, Milan Čevrljaković. Polatuzumab-Vedotin+Bendamustin+Rituximab u relaps/refraktarnom difuznom B krupnoćelijskom limfomu (R/R DBKL) – studija serije slučaja jednog centra. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
4. Milan Čevrljaković, Ivan Petković, Miljana Džunić, Aleksandar Popović, Mirjana Balić, Ana Cvetanović. Imunski posredovani hepatitis izazvan primenom pembrolizumaba kod pacijenta sa rekurentnim karcinomom glave i vrata. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
5. Aleksandar Popović, Ivan Petković, Mirjana Balić, Mirjana Todorović Mitić, Milan Čevrljaković, Dimitrije Đurđević, Ana Cvetanović. Autoimuni gastritis kod pacijenta sa melanomom lečenog adjuvantnim pembrolizumabom: prikaz slučaja. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
6. Aleksandar Popović, Ivan Petković, Mirjana Balić, Mirjana Todorović Mitić, Milan Čevrljaković, Filip Marković, Ana Cvetanović. Neželjeni efekat imunoterapije kao prediktor boljeg terapijskog odgovora- iskustvo centra. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
7.Tatjana Petković, Ivan Petković. Specifičnosti zdravstvene nege pacijenata sa metastatskim melanomom lečenih imunoterapijom. Abstract Book pp, xx-xx. 60. Kancerološka nedelja, Beograd 2023. (M64)
8. Aleksandar Popović, Ivan Petković, Mirjana Todorović Mitić, Andrija Jović, Aleksandra Dimitrijević, Mirjana Balić.Primena nivolumaba kod pacijenata sa uznapredovalim melanomom-iskustvo klinike za onkologiju. Abstract book pp 46. Beogradski Dermatološki Dani 2023 (M64)
9. Ivan Petković, Slavica Stojnev, Irena Conić, Milica Radić. Klinički aspekti limfoma gastrointestinalnog trakta. Abstract book pp 16-17. Simpozijum SLD, Medicinski fakultet Niš 2023. (M62)
10. Slavica Stojnev, Miljan Krstić, Ivan Petković, Irena Conić, Ana Ristić Petrović. Patohistološki aspekti limfoma gastrointestinalnog trakta. Abstract book pp 14-15. Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)
11. Milica Radić, Ivan Petković, Irena Conić, Ana Cvetanović, Katarina Branković. Uloga radioterapije u multidisciplinarnom tretmanu karcinoma dojke. Abstract book pp 8. Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)
12. Irena Conić, Slavica Stojnev, Miljan Krstić, Ana Ristić Petrović, Ivan Petković. Savremene terapijske opcije u lečenju bolesnica sa uznapredovalim karcinomom grlića materice. Abstract book pp 12-13. Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)
13. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović, Irena Conić. Prikaz pacijenta sa vaginalnim melanomom i kompletnim odgovorom na nivolumab. Abstract Book pp, 170-1. 59. Kancerološka nedelja, Beograd 2022. (M64)
14. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović. Primena inhibitora kontrolnih tačaka kod pacijenata sa uznapredovalim melanomom-iskustvo Klinike za onkologiju UKC Niš. Abstract Book pp, 138-9. 59. Kancerološka nedelja, Beograd 2022. (M64)
15. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović, Andrija Rančić. Prikaz pacijenta sa anorektalnim mukozalnim melanomom i sistemskim lupusom lečenog nivolumabom. Abstract Book pp, 169-70. 59. Kancerološka nedelja, Beograd 2022. (M64)
16. Ivan Petković, Aleksandar Popović, Marija Jevtić. Polatuzumab Vedotin+Bendamustin+Rituximab in relapse/ refractory diffuse large B-cell lymphoma (R/R DLBCL) -single center case series study. Abstract book pp 50, 68. 5. Kongres hematologa Srbije, Novi Sad 2022. (M64)
17. Ivan Petković, Marija Jevtić, Aleksandar Popović. Ibrutinib in relapsed/ refractory mantle cell lymphoma (R/R MCL) patients– single center experience. Abstract book pp 51, 69. 5. Kongres hematologa Srbije, Novi Sad 2022. (M64)
18. Marija Jevtić, Ivan Petković, Mladen Đorđević, Milica Stanković. Concomitant mycosis fungoides and retroperitoneal angiosarcoma- case report. Abstract book pp 44, 62. 5. Kongres hematologa Srbije, Novi Sad 2022. (M64)
19. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Extranodal NK/T–Cell Lymphoma, Nasal Type Overlapping Aggressive NK–Cell Leukemia in Course of Progression, rare entity–case report. Abstract Book pp, 142-3. 58. Kancerološka nedelja, Beograd 2021. (M64)
20. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression. Abstract Book pp, 144-5. 58. Kancerološka nedelja, Beograd 2021. (M64)
21. Miljana Džunić, Mirjana Stanić, Saša Dinić, Ivan Petković, Svetislav Vrbić, Miroslav Stojanović. Prognostički parametri kod pacijenata sa metastazama kolorektalnog karcinoma u jetri operisanih nakon konverzione biohemioterapije. Abstract Book pp, 268-9. 56. Kancerološka nedelja, Beograd 2019. (M64)
22. Ivan Petković, Emilija Vagaja, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. DA–EPOCH–R bez radioterapije vs. R–CHOP21+radioterapija su bez signifikante razlike na ishod lečenja bolesnika sa primarnim medijastinalnim B krupnoćelijskim limfomom. Abstract book pp 008, 125. 4. Kongres hematologa Srbije, Niš 2019. (M64)
23. Ivan Petković, Emilija Vagaja, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Rezidualna PET/CT pozitivnost ne korelira sa rezistencijom/ progresijom bolesti nakon DA–EPOCH–R indukcije kod primarnog medijastinalnog B krupnoćelijskog limfoma. Abstract book up 09, 100. 4. Kongres hematologa Srbije, Niš 2019. (M64) usmeno izlaganje
24. Tatjana Petković, Vesna Radojičić, Ivan Petković. Specifičnosti zdravstvene nege pacijenata sa metastatskim tumorima sa nepoznatim primarnim ishodištem. Abstract Book op, 299-300. 55. Kancerološka nedelja, Beograd 2018. (M64)
25. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Prediktivni značaj Muris skora kod bolesnika sa difuznim B krupnoćelijskim limfomom tretiranih imunohemioterapijom. Abstract book op 19, 242-3. Treći Kongres hematologa Srbije, Kragujevac 2015. (M62) usmeno izlaganje
26. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Značaj nivoa beta 2 mikroglobulina kod bolesnika sa difuznim krupnoćelijskim B limfomom u eri primene rituksimaba. Abstract book p 53, 312-3. Treći Kongres hematologa Srbije, Kragujevac 2015. (M64)
27. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Muški pol je faktor rizika za smrtni ishod kod bolesnika sa difuznim B krupnoćelijskim limfomom. Abstract book p 52, 311-2. Treći Kongres hematologa Srbije, Kragujevac 2015. (M64)
28. Ivan Petković. Uticaj starosti pacijenata na izbor tretmana kod novodijagnostikovanih difuznih B krupnoćelijskih limfoma. Abstract book pp 39, 218-22. Treći Kongres hematologa Srbije, Kragujevac 2015. (M61) predavanje po pozivu
29. Jelena Jeličić, Milena Todorović, Darko Antić, Jelena Bila, Boško Anđelić, Dragomir Stanisavljević, Vojin Vuković, Vladislava Đurašinović, Aleksandra Sretenović, Mihailo Smiljanić, Ivan Petković, Ivica Pejčić, Biljana Mihaljević. Prognostički značaj komorbiditeta kod bolesnika sa difuznim B krupnoćelijskim limfomom lečenih imunohemioterapijom. Abstract book op 21, 121. Treći Kongres hematologa Srbije, Kragujevac 2015. (M64)
30. Miljan Krstić, Slavica Stojnev, Ivan Petković, Svetislav Vrbić, Ivica Pejčić. Ekspresija STAT3 u difuznom B-krupnoćelijskom limfomu nodalne i ekstranodalne lokalizacije. Abstract book p 55, 314-5. Treći Kongres hematologa Srbije, Kragujevac 2015. (M64)
31. Vrbić Svetislav, Pejčić Ivica, Simonović Nataša, Petković Ivan. Medikamentozna onkološka terapija medularnog tireoidnog karcinoma. Zbornik radova sa recenzijom, Medicinski fakultet Niš 2009: 86-90. (M63)